HeartFlow Analysis vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Heartflow
VS
by RhythmScience

AI Verdict

These two tools are adjacent rather than direct competitors, as they address distinct aspects of cardiology. HeartFlow Analysis focuses on the non-invasive diagnosis and management of coronary artery disease through AI-powered 3D modeling of CT scans. In contrast, Rhythm360 specializes in unifying and analyzing data from various cardiac monitoring devices to provide actionable insights for hypertension, heart failure, and rhythm management, while also reducing alert fatigue.

Choose HeartFlow Analysis if…

Choose HeartFlow Analysis if your primary need is a highly accurate, non-invasive diagnostic tool for assessing coronary artery disease (CAD) severity and guiding treatment decisions. This tool excels at creating personalized 3D models of coronary arteries from CT scans, providing detailed fractional flow reserve (FFRct) and plaque analysis to determine the functional impact of blockages. It is ideal for clinicians seeking to reduce the need for invasive procedures while gaining comprehensive insights into CAD.

View HeartFlow Analysis →

Choose Rhythm360 if…

Choose Rhythm360 if your clinic requires a comprehensive, AI-powered platform to unify and manage cardiac monitoring data from a diverse range of devices for patients with hypertension, heart failure, or arrhythmias. This solution is best suited for optimizing remote patient monitoring workflows, reducing clinician alert fatigue through intelligent triage, and automating administrative tasks like CPT code documentation and EHR integration. It's designed to enhance efficiency and provide actionable insights across a broad spectrum of cardiac management.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature HeartFlow Analysis Rhythm360
Pricing Contact vendor for pricing Flexible pricing model that scales with clinic size and platform usage.
Deployment Cloud-based (AWS) Cloud-based SaaS platform
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 (Tool B) offers a HIPAA-compliant mobile application for clinicians and focuses on reducing alert fatigue, which directly improves daily clinical workflow and accessibility. HeartFlow Analysis (Tool A) primarily supports a diagnostic workflow with tools for radiologists and cardiologists, but lacks explicit features for broad, ongoing clinician mobile access or alert management.

Clinical Value

HeartFlow Analysis

HeartFlow Analysis (Tool A) provides high diagnostic accuracy for coronary artery disease (CAD) through AI-powered 3D modeling, FFRct analysis, and plaque analysis, which is FDA-cleared and supported by extensive clinical validation studies. This offers a definitive non-invasive diagnostic pathway for CAD, directly impacting critical treatment decisions.

Pricing & Value

HeartFlow Analysis

HeartFlow Analysis (Tool A) operates on a fee-for-service model with established Category I CPT codes for FFRct Analysis and AI-Enabled Quantitative Plaque Analysis, covered by Medicare and most U.S. commercial payers. This provides a clear and predictable reimbursement pathway for providers. Rhythm360 (Tool B) has a flexible SaaS model but is described as having 'premium pricing' as a potential con, despite offering automated CPT code documentation for remote monitoring.

Enterprise Readiness

Rhythm360

Rhythm360 (Tool B) demonstrates superior enterprise readiness with extensive bi-directional EHR integrations (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity) and vendor-neutral data aggregation from all major OEM cardiac monitoring devices. This allows for seamless integration into diverse and complex healthcare IT environments. HeartFlow Analysis (Tool A) is cloud-based and compliant but does not detail such broad integration capabilities.

Innovation

HeartFlow Analysis

HeartFlow Analysis (Tool A) showcases significant innovation by leveraging AI and computational fluid dynamics to create personalized 3D models and derive FFRct from standard CT scans, offering a non-invasive method to functionally assess CAD. This fundamentally transforms the diagnostic approach for coronary artery disease. Rhythm360 (Tool B) innovates in data aggregation, alert triage, and predictive algorithms for chronic condition management, which are valuable but less disruptive to core diagnostic methodologies.

Support & Docs

Rhythm360

Rhythm360 (Tool B) explicitly offers optional 24/7/365 oversight by certified cardiac technicians and provides a knowledge base with common questions and support documentation. HeartFlow Analysis (Tool A) does not detail specific support offerings or documentation in the provided facts or search results, making Rhythm360 the clear winner in this dimension based on available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature HeartFlow Analysis Rhythm360
Name HeartFlow Analysis Rhythm360
Company HeartFlow RhythmScience
Description Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Key Features AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik), AI-driven alert triage (80% faster response times, reduces alert fatigue), Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity), Automated CPT code documentation and billing (e.g., 93298, 93299, 99454, 99453, 99457), HIPAA-compliant mobile application for clinicians, AI Data Normalization (API, HL7, XML, PDF parsing via computer vision), Optional 24/7/365 oversight by certified cardiac technicians (CCTs), Heart Failure Management (predictive algorithms, GDMT optimization)
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring HeartFlow Analysis and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

HeartFlow Analysis is designed for the non-invasive diagnosis and management of coronary artery disease (CAD) by creating personalized 3D models from CT scans, including FFRct and plaque analysis. Rhythm360 is an integrated platform focused on unifying cardiac monitoring data to provide actionable insights for hypertension, heart failure, and rhythm management, aiming to reduce alert fatigue.
HeartFlow Analysis utilizes standard CT scans to generate AI-powered 3D models of coronary arteries and performs computational fluid dynamics (CFD) for blood flow simulation and FFRct analysis. Rhythm360 aggregates and normalizes data from various major OEM cardiac monitoring devices, using AI for alert triage and predictive algorithms for conditions like heart failure.
Rhythm360 explicitly offers bi-directional EHR integration with major systems such as Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, and GE Centricity. HeartFlow Analysis is cloud-based (AWS), but specific details regarding its EHR integration capabilities are not provided in the description.
HeartFlow Analysis is FDA cleared, HIPAA compliant, and has a Business Associate Agreement (BAA). Rhythm360 is HIPAA compliant and has a BAA, but its description does not explicitly mention FDA clearance.
Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) as part of its comprehensive platform. HeartFlow Analysis focuses on providing its AI-powered diagnostic software and analysis, with no mention of additional human oversight services.

Backers

Who funded each tool's parent company.

HeartFlow Analysis

AI Tool Finder
AI-powered search. Results may not be comprehensive.